Provider
Afrezza (regular human insulin, inhaled) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: May 01, 2025
Search Results
Displaying 2691 - 2700 of 3878 results
Provider
QP23-22 Blue Cross and Blue Shield of Minnesota Collaboration with VillageHealth
Program effective Date: Mar 23, 2022
Provider
QP17-22 Commercial Pharmacy Benefit Exclusion for Vabysmo™ and Xipere™
Program effective Date: Mar 09, 2022
Provider
QP18-22 Minnesota Health Care Programs Housing Stabilization Referrals
Program effective Date: Mar 09, 2022
Provider
QP19-22 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective May 1, 2022
Program effective Date: Mar 09, 2022
Provider
QP20-22 MHCP Pharmacy Benefit Exclusion for Select Medications
Program effective Date: Mar 09, 2022
Provider
QP21-22 Reminder: Replacement Claim, Adjustment Request or Appeal Submission
Program effective Date: Mar 09, 2022
Provider
QP22-22 Second Opinion Pilot for Select MSK Procedures Available to Commercial Fully Insured and Individual Members
Program effective Date: Mar 09, 2022
Provider
2022 March Provider Press
Program effective Date: Mar 01, 2022